UNII,MainDrug,NDC,Strength,Formulation,INGREDIENT_NAME,ROUTE,DOSAGE_FORM,CAS_NUMBER,POTENCY_AMOUNT,POTENCY_UNIT,MAXIMUM_DAILY_EXPOSURE,MAXIMUM_DAILY_EXPOSURE_UNIT,RECORD_UPDATED
C151H8M554,infliximab,57894-030,100 mg  in 10 mL," injection, powder, lyophilized, for solution",SUCROSE,INTRAVENOUS,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",57501.0,,,2000.0,mg,
6OZP39ZG8H,infliximab,57894-030,100 mg  in 10 mL," injection, powder, lyophilized, for solution",POLYSORBATE 80,INTRAVENOUS,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",9005656.0,,,900.0,mg,
593YOG76RN,infliximab,57894-030,100 mg  in 10 mL," injection, powder, lyophilized, for solution","SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE",INTRAVENOUS,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",10049215.0,15.55,mg,,,
94255I6E2T,infliximab,57894-030,100 mg  in 10 mL," injection, powder, lyophilized, for solution","SODIUM PHOSPHATE, DIBASIC, DIHYDRATE",INTRAVENOUS,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",10028247.0,,,3.0,mg,
